Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maurizio Taddei

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Frontiers in Oncology|February 11, 2020
ErbB2 Targeted Epigenetic Modulation: Anti-tumor Efficacy of the ADC Trastuzumab-HDACi ST8176AA1Ferdinando Maria Milazzo, Loredana Vesci, Anna Maria Anastasi, et al.
Chemical Communications (Cambridge, England)|January 12, 2021
Antibody drug conjugates with hydroxamic acid cargos for histone deacetylase (HDAC) inhibitionClaudio Cianferotti, Valentina Faltoni, Elena Cini, et al.
Journal of Medicinal Chemistry|September 19, 2014
ST7612AA1, a thioacetate-ω(γ-lactam carboxamide) derivative selected from a novel generation of oral HDAC inhibitorsGiuseppe Giannini, Loredana Vesci, Gianfranco Battistuzzi, et al.
Current Topics in Medicinal Chemistry|August 26, 2016
Benzodiazepine Scaffold as Drug-like Molecular Simplification of FR235222: A Chemical Tool for Exploring HDAC InhibitionRosario Randino, Ilaria Moronese, Elena Cini, et al.
Pharmacological Research|July 20, 2023
Targeting GLI1 and GLI2 with small molecule inhibitors to suppress GLI-dependent transcription and tumor growthLuisa Maresca, Enrica Crivaro, Francesca Migliorini, et al.
Journal of Medicinal Chemistry|March 5, 2014
Synthesis and evaluation of new Hsp90 inhibitors based on a 1,4,5-trisubstituted 1,2,3-triazole scaffoldMaurizio Taddei, Serena Ferrini, Luca Giannotti, et al.
Life Sciences|November 8, 2025
Drug enteric metabolism in gut microbiota-brain crosstalkSamuele Maramai, Maurizio Taddei, Andrea Castagnetti, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Frontiers in Oncology|February 11, 2020
ErbB2 Targeted Epigenetic Modulation: Anti-tumor Efficacy of the ADC Trastuzumab-HDACi ST8176AA1Ferdinando Maria Milazzo, Loredana Vesci, Anna Maria Anastasi, et al.
Chemical Communications (Cambridge, England)|January 12, 2021
Antibody drug conjugates with hydroxamic acid cargos for histone deacetylase (HDAC) inhibitionClaudio Cianferotti, Valentina Faltoni, Elena Cini, et al.
Journal of Medicinal Chemistry|September 19, 2014
ST7612AA1, a thioacetate-ω(γ-lactam carboxamide) derivative selected from a novel generation of oral HDAC inhibitorsGiuseppe Giannini, Loredana Vesci, Gianfranco Battistuzzi, et al.
Current Topics in Medicinal Chemistry|August 26, 2016
Benzodiazepine Scaffold as Drug-like Molecular Simplification of FR235222: A Chemical Tool for Exploring HDAC InhibitionRosario Randino, Ilaria Moronese, Elena Cini, et al.
Pharmacological Research|July 20, 2023
Targeting GLI1 and GLI2 with small molecule inhibitors to suppress GLI-dependent transcription and tumor growthLuisa Maresca, Enrica Crivaro, Francesca Migliorini, et al.
Journal of Medicinal Chemistry|March 5, 2014
Synthesis and evaluation of new Hsp90 inhibitors based on a 1,4,5-trisubstituted 1,2,3-triazole scaffoldMaurizio Taddei, Serena Ferrini, Luca Giannotti, et al.
Life Sciences|November 8, 2025
Drug enteric metabolism in gut microbiota-brain crosstalkSamuele Maramai, Maurizio Taddei, Andrea Castagnetti, et al.
Pageof 7